Evidence map›Paper›PMID 25428391›Full record

ArticleMedical oncology (Northwood, London, England)2015

Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer.

You-Ming Lei, Yun-Fen Zu, Jiying Wang, Song Bai, Yun-Fei Shi, Rou Shi, Jin Duan, Daolei Cui, Jianlan Chen, Yang Xiang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. MiR-101: a potential therapeutic target of cancers.American journal of translational research · 2018
    Review
  7. The contrasting roles of inflammasomes in cancer.American journal of cancer research · 2018
    Review
  8. MicroRNAs in lung cancer.Oncotarget · 2017
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

You-Ming LeiDepartment of Vip Surgery Ward and Department of Biotherapy, The First Affiliated Hospital of Kunming Medical University of Medical Science, Kunming, 650032, Yunnan, China.
Yun-Fen Zu
Jiying Wang
Song Bai
Yun-Fei Shi
Rou Shi
Jin Duan
Daolei Cui
Jianlan Chen
Yang Xiang
Jian Dong
First Affiliated Hospital of Kunming Medical University · CNKunming Medical University · CNSecond People's Hospital of Yunnan Province · CNKunming Institute of Zoology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer may be a result of complex factors. Small mineral particle is the well-known inducer of lung cancer. Previous study revealed the high morbidity of lung cancer in Xuan Wei in China, and the main cause of lung cancer is the use of smoky coal there. And it is generally accepted that chronic inflammation induced by small mineral particle may be a cause of lung cancer. But the relationship between chronic lung inflammation and lung cancer is largely unknown. In the present study, we found that silica particle was able to induce the secretion of interleukin-1β from a Xuan Wei lung cancer cell line, XWLC-05. At the same time, microRNA-101 (mir-101) was found to be downregulated by the treatment of silica particle. Interestingly, the interleukin 1 receptor antagonist and interleukin-1β antibody can reduce silica particle-induced downregulation of mir-101. Twenty-four Xuan Wei lung tumor tissues were collected to detect the expression level of mir-101 and enhancer of zeste homolog 2 (EZH2), which is the potential target of mir-101. The results showed that mir-101 was down-regulated and EZH2 were upregulated. Subsequently, the roles of mir-101 and EZH2 in tumor growth and progression in vitro were tested. Overexpression of mir-101 mimics was able to suppress the expression of EZH2 in XWLC-05 cells. And this resulted in the inhibited tumor cell growth and attenuated cell migration. The results in the present study showed that particle can induce the secretion of interleukin-1β. Interleukin-1β subsequently induces the downregulation of mir-101, which may result in the upregulated level of EZH2, and occurrence of lung cancer. We for the first time proposed the role interleukin-1β-mir-101-EZH2 axes in the particle-induced lung cancer. Further study may be needed to decipher the detailed mechanism involved.

Indexed as

Blotting, WesternEnhancer of Zeste Homolog 2 ProteinGene Expression Regulation, NeoplasticHumansInterleukin-1betaLung NeoplasmsMicroRNAsParticulate MatterPolycomb Repressive Complex 2Reverse Transcriptase Polymerase Chain ReactionSilicon DioxideUp-RegulationEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanInterleukin-1betaMicroRNAsMIRN101 microRNA, humanParticulate MatterPolycomb Repressive Complex 2Silicon Dioxide

Identifiers

PMID25428391
OpenAlexW2020256536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.